EKF Diagnostics Holdings plc
("EKF", the "Company")
PDMR dealing
EKF Diagnostics Holdings plc (AIM: EKF) announces that on 21 March 2017, the Company was notified that Harwood Capital LLP ("Harwood") acquired 8,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.
Following the above transaction, which was completed on 20 March 2017 at a price of 19.5p pence per share, NAIT's interest is now in 98,000,000 Ordinary Shares, representing 21.12% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.
The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 138,000,000 Ordinary Shares, representing 29.73% of the Company's issued share capital.
EKF Diagnostics Holdings plc |
www.ekfdiagnostics.com |
Christopher Mills, Non-Executive Chairman |
Tel: 029 2071 0570 |
Julian Baines, CEO |
|
Richard Evans, FD & COO |
|
|
|
N+1 Singer (Nomad & Broker) |
Tel: 020 7496 3000 |
Alex Price / Shaun Dobson / Alex Laughton-Scott |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or ekf@walbrookpr.com |
Paul McManus / Lianne Cawthorne |
Mob: 07980 541 893 / 07584 391 303 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 |
Details of the person discharging managerial responsibilities / person closely associated |
a) |
Name |
Harwood Capital LLP, as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT") |
2 |
Reason for the notification |
a) |
Position/status |
Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood Capital LLP and a director and shareholder in NAIT |
b) |
Initial notification /Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
EKF Diagnostics Holdings plc |
b) |
LEI |
213800DXTF3EAUK1AR05 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1p each ("Ordinary Shares") ISIN Code: GB0031509804 |
b) |
Nature of the transaction |
Acquisition of shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
19.5p |
8,000,000 |
|
d) |
Aggregated information - Aggregated volume - Price |
n/a |
e) |
Date of the transaction |
20 March 2017 |
f) |
Place of the transaction |
London Stock Exchange |